Back
BMO Low Volatility Emerging Markets Equity ETF Vs. Agios Pharmaceuticals Industry Stock Comparison
Sell
27
ZLE.TO
BMO Low Volatility Emerging Markets Equity ETF
Last Price:
$18.80
Seasonality Move:
-0.87%
Sell
8
AGIO
Agios Pharmaceuticals
Last Price:
$32.16
Seasonality Move:
10.13%
Sell
27
BMO Low Volatility Emerging Markets Equity ETF (ZLE.TO)
is a Sell
Is BMO Low Volatility Emerging Markets Equity ETF a Buy, Sell or Hold?
-
The current BMO Low Volatility Emerging Markets Equity ETF [ZLE.TO] share price is $18.80. The Score for ZLE.TO is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
ZLE.TO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
8
Agios Pharmaceuticals (AGIO)
is a Sell
Is Agios Pharmaceuticals a Buy, Sell or Hold?
-
The current Agios Pharmaceuticals [AGIO] share price is $32.19. The Score for AGIO is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
-
AGIO is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing an extreme reading that indicates risk could be especially high.
ZLE.TO Stock Price Chart
What is BMO Low Volatility Emerging Markets Equity ETF's stock price today?
-
The BMO Low Volatility Emerging Markets Equity ETF share price today is $18.80Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ZLE.TO is experiencing selling pressure, which indicates risk of future bearish movement.
AGIO Stock Price Chart
What is Agios Pharmaceuticals's stock price today?
-
The Agios Pharmaceuticals share price today is $32.19Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AGIO is experiencing slight buying pressure.
ZLE.TO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.08 | Sell |
Relative Strength Index (14 RSI): | 31.09 | Sell |
Chaikin Money Flow: | -6631 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (19.21 - 19.85) | Sell |
Bollinger Bands (100): | (18.85 - 19.83) | Sell |
AGIO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -5.19 | Sell |
Relative Strength Index (14 RSI): | 26.3 | Sell |
Chaikin Money Flow: | 119640 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (33.09 - 54.37) | Sell |
Bollinger Bands (100): | (39.22 - 53.24) | Sell |
ZLE.TO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 19.45 | Sell |
20-day SMA: | 19.58 | Sell |
50-day SMA: | 19.5 | Sell |
200-day SMA: | 18.69 | Buy |
8-day EMA: | 19.31 | Sell |
20-day EMA: | 19.48 | Sell |
50-day EMA: | 19.47 | Sell |
200-day EMA: | 18.8 | Sell |
AGIO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 33.4 | Sell |
20-day SMA: | 39.89 | Sell |
50-day SMA: | 47.81 | Sell |
200-day SMA: | 42.22 | Sell |
8-day EMA: | 33.87 | Sell |
20-day EMA: | 39 | Sell |
50-day EMA: | 44.23 | Sell |
200-day EMA: | 41.89 | Sell |
BMO Low Volatility Emerging Markets Equity ETF Earnings Growth & ZLE.TO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Agios Pharmaceuticals Earnings Growth & AGIO Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $9.62 per share, a decrease next quarter of $0.00 per share, a decrease this year of $16.90 per share, and an increase next year of $0.54 per share.
BMO Low Volatility Emerging Markets Equity ETF Technical Analysis
Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | Dec 24 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
16 | 17 | 18 | 19 | 20 | 24 | 27 | 30 | 31 | 02 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Agios Pharmaceuticals Technical Analysis
Dec 19 | Dec 20 | Dec 23 | Dec 24 | Dec 26 | Dec 27 | Dec 30 | Dec 31 | Jan 2 | Jan 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | Jan | |||||||||
19 | 20 | 23 | 24 | 26 | 27 | 30 | 31 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |